[{"NetIncomeLoss_1_Q2_USD":-10556000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":83000.0,"InterestPaidNet_2_Q2_USD":571000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-10000.0,"Depreciation_2_Q2_USD":157000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1352000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":5441000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":154000.0,"AssetsCurrent_0_Q2_USD":353817000.0,"OperatingLeaseExpense_2_Q2_USD":166000.0,"OperatingLeaseExpense_1_Q2_USD":90000.0,"LongTermDebt_0_Q2_USD":0.0,"RepaymentsOfLongTermDebt_2_Q2_USD":4683000.0,"PrepaidExpenseAndOtherAssets_0_Q2_USD":1371000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":0.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2985000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":149000.0,"DebtInstrumentUnamortizedDiscountNoncurrent_0_Q2_USD":0.0,"ConversionOfStockAmountIssued1_2_Q2_USD":136920000.0,"CommonStockSharesIssued_0_Q2_shares":37527000.0,"Assets_0_Q2_USD":355355000.0,"ShareBasedCompensation_2_Q2_USD":1136000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":483000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.24,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LongTermDebtCurrent_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":40000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":8586000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2925000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":8984000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":2.73,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":719000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":0.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-1320000.0,"CommonStockValue_0_Q2_USD":4000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":136920000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1908000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":163000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":272933000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":5715000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":22680000.0,"InvestmentIncomeNonoperating_1_Q2_USD":18000.0,"DeferredCompensationLiabilityCurrent_0_Q2_USD":1319000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":75000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":75000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.004,"OtherAssetsNoncurrent_0_Q2_USD":643000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":352446000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":679000.0,"Liabilities_0_Q2_USD":25059000.0,"OperatingLeaseLiability_0_Q2_USD":679000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4889000.0,"InvestmentIncomeNonoperating_2_Q2_USD":161000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":14528000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":158000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":257992000.0,"DeferredFinanceCostsCurrentNet_0_Q2_USD":0.0,"ProceedsFromConvertibleDebt_2_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":37527000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"RestrictedCashNoncurrent_0_Q2_USD":124000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1800000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":687000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14931000.0,"DebtInstrumentUnamortizedDiscountCurrent_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":12000.0,"LiabilitiesCurrent_0_Q2_USD":11620000.0,"NonoperatingIncomeExpense_2_Q2_USD":-123000.0,"NonoperatingIncomeExpense_1_Q2_USD":-188000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q2_USD":34000.0,"InterestExpense_2_Q2_USD":209000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":16000.0,"LongTermDebtNoncurrent_0_Q2_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.055,"AdditionalPaidInCapital_0_Q2_USD":369118000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":352570000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":106000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":163000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":287000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":2200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":771000.0,"NetIncomeLoss_2_Q2_USD":-16641000.0,"InterestExpense_1_Q2_USD":131000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":392000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-38826000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":29000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":2899000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1541000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":153722.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":130302.0,"OperatingIncomeLoss_2_Q2_USD":-16518000.0,"OperatingIncomeLoss_1_Q2_USD":-10368000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":298080000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4860000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":11.02,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.44,"LiabilitiesAndStockholdersEquity_0_Q2_USD":355355000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2862000.0,"PreferredStockSharesAuthorized_0_Q2_shares":40000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":687000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":51000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":2571000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":0.0,"OperatingExpenses_2_Q2_USD":19417000.0,"OperatingExpenses_1_Q2_USD":11909000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":676000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.91,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.23,"ProfitLoss_2_Q2_USD":-16641000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":330296000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":12760000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":10000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1136000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":0.0,"Ticker":"RNA","CIK":"1599901","name":"AVIDITY BIOSCIENCES, INC.","OfficialName":"Avidity Biosciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"872955496.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200811"}]